These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 280361)

  • 1. Remission induction in chronic granulocytic leukaemia using intermittent high-dose busulphan.
    Douglas ID; Wiltshaw E
    Br J Haematol; 1978 Sep; 40(1):59-64. PubMed ID: 280361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic granulocytic leukaemia with Ph 1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia.
    Finney R; McDonald GA; Baikie AG; Douglas AS
    Br J Haematol; 1972 Sep; 23(3):283-8. PubMed ID: 4507535
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic granulocytic leukaemia with repeated single doses of busulphan.
    Vicariot M; Goldman JM; Catovsky D; Galton DA
    Eur J Cancer (1965); 1979 Apr; 15(4):559-63. PubMed ID: 285861
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship of the duration of the chronic phase in chronic granulocytic leukaemia to the need for treatment during the first year after diagnosis.
    Wareham NJ; Johnson SA; Goldman JM
    Cancer Chemother Pharmacol; 1982; 8(2):205-10. PubMed ID: 6955071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-five year survival of chronic granulocytic leukaemia with spontaneous karyotype conversion.
    Singer CR; McDonald GA; Douglas AS
    Br J Haematol; 1984 Jun; 57(2):309-13. PubMed ID: 6587904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of chronic granulocytic leukemia.
    Crosby WH
    Arch Intern Med; 1977 Dec; 137(12):1717-8. PubMed ID: 270965
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic granulocytic leukaemia. Comparison of uracil mustard and busulphan.
    Herrmann RP; Dougan L; Holt JA; Jackson JM; Matthews ML; Nelson AJ; Stenhouse NS; Woodliff HJ
    Med J Aust; 1972 Apr; 1(16):789-91. PubMed ID: 4503393
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of chronic myeloid leukemia with repeated single doses of busulfan.
    Sullivan JR; Hurley TH; Bolton JH
    Cancer Treat Rep; 1977; 61(1):43-5. PubMed ID: 266418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic remission in a Ph1-positive case of chronic myelogenous leukaemia.
    Zago MA; Costa FF; Bottura C
    Scand J Haematol; 1979 Jan; 22(1):91-5. PubMed ID: 284583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of chronic granulocytic leukaemia.
    Canellos GP
    Clin Haematol; 1977 Feb; 6(1):113-28. PubMed ID: 334404
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged survival in chronic granulocytic leukaemia after busulphan induced hypoplasia and karyotype conversion.
    Bennett M; Lewis D; Walker H
    Br J Haematol; 1985 Apr; 59(4):738-40. PubMed ID: 3857075
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of high dose busulphan on leukaemic progenitor cells in chronic myeloid leukaemia.
    Morstyn G; Sullivan J; Fairhead S; Cowling D; Hurley T
    Aust N Z J Med; 1981 Dec; 11(6):609-14. PubMed ID: 6949537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil function in chronic granulocytic leukaemia before and after busulphan treatment.
    Whittaker JA; Khurshid M; Hughes HR
    Br J Haematol; 1974 Dec; 28(4):541-9. PubMed ID: 4616717
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic granulocytic leukaemia: comparison of radiotherapy and busulphan therapy. Report of the Medical Research Council's working party for therapeutic trials in leukaemia.
    Br Med J; 1968 Jan; 1(5586):201-8. PubMed ID: 5235190
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chromosome aberrations in busulphan therapy (author's transl)].
    Gebhart E; Schwanitz G; Hartwich G
    Dtsch Med Wochenschr; 1974 Jan; 99(2):52-56. PubMed ID: 4520646
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic myeloid leukaemia and a myasthenic syndrome.
    Wohl MA; Wood JK
    Acta Haematol; 1979; 62(4):214-8. PubMed ID: 119414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal hypertension in a patient with chronic myeloid leukaemia.
    Foadi MD; Shaw S; Paradinas FJ
    Postgrad Med J; 1977 May; 53(619):267-9. PubMed ID: 267281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complete cytogenetic remission of chronic myeloid leukemia with low-dose interferon alfa-2b and monthly high-dose busulfan].
    Armenta D; Espallargas C; Paz A; Rodríguez Martorel J; Ladines R; Alvarez C; Román J; Andrés P
    Sangre (Barc); 1996 Dec; 41(6):465-7. PubMed ID: 9148424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Busulphan versus combination chemotherapy for initial treatment of chronic granulocytic leukaemia.
    Jacobs P
    Am J Hematol; 1986 Aug; 22(4):375-80. PubMed ID: 3460327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic granulocytic leukaemia (CGL): results of continuous busulphan mono-chemotherapy in 160 cases (1960-1980) (author's transl)].
    Sánchez Fayos J; Outeiriño J; de Villalobos E; Valera M; Alonso M; Calabuig MT; Paniagua G
    Sangre (Barc); 1981; 26(1):65-71. PubMed ID: 6942520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.